Dapagliflozin suppresses glucagon signaling in rodent models of diabetes
May-Yun Wang(The University of Texas Southwestern Medical Center), Michael G. Roth(Southwestern Medical Center)
Cited by 33
Related Papers
SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
|Nature Communications|2017|115
Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway
|Proceedings of the National Academy of Sciences|2015|112